Abstract
NPM (nucleophosmin/B23) is a major nucleolar protein which is 20 times more abundant in tumor or proliferating cells than in normal resting cells. Recently, it was found that NPM gene is located at the breakpoints of the t(2:5), t(3:5) and t(5:17) chromosome translocation. To understand the human NPM gene's structure and regulation, four genomic clones were isolated from the human chromosome 5 library and their DNA sequences analyzed. The human NPM gene has 12 exons of sizes ranging from 58 to 358 bp. The chromosome breakpoint for t(2:5) and t(5:17) translocation is within intron 4 and the breakpoint for t(3:5) translocation is within intron 6. The initiation site is located 96 bp upstream from the ATG site. A typical TATA box (at -25 nt) and a GC box (at -65 nt) were identified in the promoter region. We identified two gel-shift bands (A and B) with DNA fragment E (-741/-250 nt) by EMSA. A DNA footprint was observed at (-371/-344 nt) with the nuclear extract. A double stranded DNA with the footprint sequence (-371/-344 nt) competed the formation of gel-shift bands A and B in EMSA suggesting that proteins A and B bind to the footprint region. We confirmed that protein A is transcription factor YY1. These results suggest that YY1 may play a role in NPM gene expression. This is the first report on human NPM gene structure and sequence.
Full Text
The Full Text of this article is available as a PDF (234.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adachi Y., Copeland T. D., Hatanaka M., Oroszlan S. Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23. J Biol Chem. 1993 Jul 5;268(19):13930–13934. [PubMed] [Google Scholar]
- Bullrich F., Morris S. W., Hummel M., Pileri S., Stein H., Croce C. M. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res. 1994 Jun 1;54(11):2873–2877. [PubMed] [Google Scholar]
- Chan P. K., Aldrich M. B., Yung B. Y. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells. Cancer Res. 1987 Jul 15;47(14):3798–3801. [PubMed] [Google Scholar]
- Chan P. K., Aldrich M., Busch H. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Exp Cell Res. 1985 Nov;161(1):101–110. doi: 10.1016/0014-4827(85)90494-x. [DOI] [PubMed] [Google Scholar]
- Chan P. K. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism). Exp Cell Res. 1992 Nov;203(1):174–181. doi: 10.1016/0014-4827(92)90053-b. [DOI] [PubMed] [Google Scholar]
- Chan W. Y., Liu Q. R., Borjigin J., Busch H., Rennert O. M., Tease L. A., Chan P. K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry. 1989 Feb 7;28(3):1033–1039. doi: 10.1021/bi00429a017. [DOI] [PubMed] [Google Scholar]
- Chang J. H., Olson M. O. A single gene codes for two forms of rat nucleolar protein B23 mRNA. J Biol Chem. 1989 Jul 15;264(20):11732–11737. [PubMed] [Google Scholar]
- Chang J. H., Olson M. O. Structure of the gene for rat nucleolar protein B23. J Biol Chem. 1990 Oct 25;265(30):18227–18233. [PubMed] [Google Scholar]
- Denny C. T., Shah N. P., Ogden S., Willman C., McConnell T., Crist W., Carroll A., Witte O. N. Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4254–4258. doi: 10.1073/pnas.86.11.4254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dignam J. D., Martin P. L., Shastry B. S., Roeder R. G. Eukaryotic gene transcription with purified components. Methods Enzymol. 1983;101:582–598. doi: 10.1016/0076-6879(83)01039-3. [DOI] [PubMed] [Google Scholar]
- Fankhauser C., Izaurralde E., Adachi Y., Wingfield P., Laemmli U. K. Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol. 1991 May;11(5):2567–2575. doi: 10.1128/mcb.11.5.2567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feuerstein N., Chan P. K., Mond J. J. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem. 1988 Aug 5;263(22):10608–10612. [PubMed] [Google Scholar]
- Feuerstein N., Mond J. J. "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem. 1987 Aug 15;262(23):11389–11397. [PubMed] [Google Scholar]
- Finch R. A., Chan P. K. ATP depletion affects NPM translocation and exportation of rRNA from nuclei. Biochem Biophys Res Commun. 1996 May 15;222(2):553–558. doi: 10.1006/bbrc.1996.0782. [DOI] [PubMed] [Google Scholar]
- Finch R. A., Revankar G. R., Chan P. K. Nucleolar localization of nucleophosmin/B23 requires GTP. J Biol Chem. 1993 Mar 15;268(8):5823–5827. [PubMed] [Google Scholar]
- Flanagan J. R., Becker K. G., Ennist D. L., Gleason S. L., Driggers P. H., Levi B. Z., Appella E., Ozato K. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol. 1992 Jan;12(1):38–44. doi: 10.1128/mcb.12.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fujimoto J., Shiota M., Iwahara T., Seki N., Satoh H., Mori S., Yamamoto T. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4181–4186. doi: 10.1073/pnas.93.9.4181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hariharan N., Kelley D. E., Perry R. P. Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9799–9803. doi: 10.1073/pnas.88.21.9799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heisterkamp N., Stam K., Groffen J., de Klein A., Grosveld G. Structural organization of the bcr gene and its role in the Ph' translocation. 1985 Jun 27-Jul 3Nature. 315(6022):758–761. doi: 10.1038/315758a0. [DOI] [PubMed] [Google Scholar]
- Inouye C. J., Seto E. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem. 1994 Mar 4;269(9):6506–6510. [PubMed] [Google Scholar]
- Lamant L., Meggetto F., al Saati T., Brugières L., de Paillerets B. B., Dastugue N., Bernheim A., Rubie H., Terrier-Lacombe M. J., Robert A. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996 Jan 1;87(1):284–291. [PubMed] [Google Scholar]
- Lieberman P. M., Hardwick J. M., Sample J., Hayward G. S., Hayward S. D. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol. 1990 Mar;64(3):1143–1155. doi: 10.1128/jvi.64.3.1143-1155.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Q. R., Chan P. K. Characterization of seven processed pseudogenes of nucleophosmin/B23 in the human genome. DNA Cell Biol. 1993 Mar;12(2):149–156. doi: 10.1089/dna.1993.12.149. [DOI] [PubMed] [Google Scholar]
- Maxam A. M., Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499–560. doi: 10.1016/s0076-6879(80)65059-9. [DOI] [PubMed] [Google Scholar]
- Morris S. W., Kirstein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994 Mar 4;263(5151):1281–1284. doi: 10.1126/science.8122112. [DOI] [PubMed] [Google Scholar]
- Natesan S., Gilman M. Z. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 1993 Dec;7(12B):2497–2509. doi: 10.1101/gad.7.12b.2497. [DOI] [PubMed] [Google Scholar]
- Nordeen S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988 May;6(5):454–458. [PubMed] [Google Scholar]
- Park K., Atchison M. L. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9804–9808. doi: 10.1073/pnas.88.21.9804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patterson S. D., Grossman J. S., D'Andrea P., Latter G. I. Reduced numatrin/B23/nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts. J Biol Chem. 1995 Apr 21;270(16):9429–9436. doi: 10.1074/jbc.270.16.9429. [DOI] [PubMed] [Google Scholar]
- Redner R. L., Rush E. A., Faas S., Rudert W. A., Corey S. J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood. 1996 Feb 1;87(3):882–886. [PubMed] [Google Scholar]
- Sandlund J. T., Downing J. R., Crist W. M. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996 May 9;334(19):1238–1248. doi: 10.1056/NEJM199605093341906. [DOI] [PubMed] [Google Scholar]
- Shi Y., Seto E., Chang L. S., Shenk T. Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 1991 Oct 18;67(2):377–388. doi: 10.1016/0092-8674(91)90189-6. [DOI] [PubMed] [Google Scholar]
- Sweet P., Chan P. K., Slater L. M. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells. Cancer Res. 1989 Feb 1;49(3):677–680. [PubMed] [Google Scholar]
- Valdez B. C., Perlaky L., Henning D., Saijo Y., Chan P. K., Busch H. Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem. 1994 Sep 23;269(38):23776–23783. [PubMed] [Google Scholar]
- Wells R. D., Collier D. A., Hanvey J. C., Shimizu M., Wohlrab F. The chemistry and biology of unusual DNA structures adopted by oligopurine.oligopyrimidine sequences. FASEB J. 1988 Nov;2(14):2939–2949. [PubMed] [Google Scholar]
- Wu F. K., Garcia J. A., Harrich D., Gaynor R. B. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J. 1988 Jul;7(7):2117–2130. doi: 10.1002/j.1460-2075.1988.tb03051.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu M. H., Lam C. Y., Yung B. Y. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP. Biochem J. 1995 Feb 1;305(Pt 3):987–992. doi: 10.1042/bj3050987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang W. M., Inouye C. J., Seto E. Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. J Biol Chem. 1995 Jun 23;270(25):15187–15193. doi: 10.1074/jbc.270.25.15187. [DOI] [PubMed] [Google Scholar]
- Yoneda-Kato N., Look A. T., Kirstein M. N., Valentine M. B., Raimondi S. C., Cohen K. J., Carroll A. J., Morris S. W. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene. 1996 Jan 18;12(2):265–275. [PubMed] [Google Scholar]
- Yoshida K., Narita M., Fujinaga K. Binding sites of HeLa cell nuclear proteins on the upstream region of adenovirus type 5 E1A gene. Nucleic Acids Res. 1989 Dec 11;17(23):10015–10034. doi: 10.1093/nar/17.23.10015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yung B. Y., Busch H., Chan P. K. Effects of luzopeptins on protein B23 translocation and ribosomal RNA synthesis in HeLa cells. Cancer Res. 1986 Feb;46(2):922–925. [PubMed] [Google Scholar]
- Yung B. Y., Busch R. K., Busch H., Mauger A. B., Chan P. K. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1). Biochem Pharmacol. 1985 Nov 15;34(22):4059–4063. doi: 10.1016/0006-2952(85)90387-9. [DOI] [PubMed] [Google Scholar]